rs113054726
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4BP7BS1
This summary comes from the ClinGen Evidence Repository: NM_001754.5(RUNX1):c.967+8A>T is an intronic variant. MAF of 0.00048 (0.048%, 12/24970 alleles) in the African subpopulation of the gnomAD V2 cohort is between 0.00015 (0.015%) and 0.0015 (0.15%) (BS1). REVEL score not applicable and SpliceAI ∆ scores ≤ 0.20 (BP4). Evolutionary conservation prediction algorithms predict the site as not being conserved (PhyloP score -0.997, <2) (BP7). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BS1, BP4, BP7. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10014257/MONDO:0100083/008
Frequency
Consequence
NM_001754.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251474Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135906
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461836Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 727222
GnomAD4 genome AF: 0.000112 AC: 17AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74366
ClinVar
Submissions by phenotype
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Benign:2
NM_001754.5(RUNX1):c.967+8A>T is an intronic variant. MAF of 0.00048 (0.048%, 12/24970 alleles) in the African subpopulation of the gnomAD V2 cohort is between 0.00015 (0.015%) and 0.0015 (0.15%) (BS1). REVEL score not applicable and SpliceAI ∆ scores <= 0.20 (BP4). Evolutionary conservation prediction algorithms predict the site as not being conserved (PhyloP score -0.997, <2) (BP7). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BS1, BP4, BP7. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at